Prelude Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-2,132
| Closed | -$236K | – | 1193 |
|
2025
Q1 | $236K | Buy |
+2,132
| New | +$236K | 0.02% | 740 |
|
2022
Q4 | – | Sell |
-1,948
| Closed | -$207K | – | 1375 |
|
2022
Q3 | $207K | Buy |
+1,948
| New | +$207K | 0.01% | 1034 |
|
2020
Q4 | – | Sell |
-1,538
| Closed | -$148K | – | 1284 |
|
2020
Q3 | $148K | Buy |
1,538
+1,473
| +2,266% | +$142K | 0.01% | 576 |
|
2020
Q2 | $8K | Buy |
+65
| New | +$8K | ﹤0.01% | 1099 |
|
2019
Q2 | – | Sell |
-498
| Closed | -$44K | – | 1553 |
|
2019
Q1 | $44K | Buy |
498
+259
| +108% | +$22.9K | ﹤0.01% | 817 |
|
2018
Q4 | $17K | Sell |
239
-11,805
| -98% | -$840K | ﹤0.01% | 941 |
|
2018
Q3 | $1.48M | Sell |
12,044
-3,141
| -21% | -$386K | 0.09% | 167 |
|
2018
Q2 | $1.49M | Sell |
15,185
-3,553
| -19% | -$349K | 0.09% | 174 |
|
2018
Q1 | $1.55M | Buy |
18,738
+4,033
| +27% | +$334K | 0.11% | 146 |
|
2017
Q4 | $1.14M | Sell |
14,705
-28,554
| -66% | -$2.22M | 0.09% | 196 |
|
2017
Q3 | $2.65M | Buy |
43,259
+9,241
| +27% | +$566K | 0.24% | 79 |
|
2017
Q2 | $1.57M | Buy |
34,018
+13,493
| +66% | +$621K | 0.15% | 130 |
|
2017
Q1 | $889K | Buy |
20,525
+3,699
| +22% | +$160K | 0.09% | 229 |
|
2016
Q4 | $651K | Sell |
16,826
-11,560
| -41% | -$447K | 0.08% | 255 |
|
2016
Q3 | $1.44M | Buy |
28,386
+21,825
| +333% | +$1.1M | 0.15% | 142 |
|
2016
Q2 | $298K | Sell |
6,561
-500
| -7% | -$22.7K | 0.04% | 361 |
|
2016
Q1 | $279K | Buy |
7,061
+367
| +5% | +$14.5K | 0.04% | 378 |
|
2015
Q4 | $379K | Sell |
6,694
-1,400
| -17% | -$79.3K | 0.06% | 309 |
|
2015
Q3 | $322K | Buy |
8,094
+6,794
| +523% | +$270K | 0.05% | 358 |
|
2015
Q2 | $62K | Buy |
1,300
+800
| +160% | +$38.2K | 0.01% | 997 |
|
2015
Q1 | $20K | Buy |
+500
| New | +$20K | ﹤0.01% | 1674 |
|
2014
Q4 | – | Sell |
-2,500
| Closed | -$39K | – | 1950 |
|
2014
Q3 | $39K | Sell |
2,500
-5,000
| -67% | -$78K | 0.01% | 1372 |
|
2014
Q2 | $111K | Sell |
7,500
-13,700
| -65% | -$203K | 0.01% | 941 |
|
2014
Q1 | $341K | Buy |
+21,200
| New | +$341K | 0.05% | 477 |
|
2013
Q4 | – | Sell |
-1,500
| Closed | -$17K | – | 1681 |
|
2013
Q3 | $17K | Buy |
+1,500
| New | +$17K | ﹤0.01% | 1106 |
|